Stock Track | Ultragenyx Pharmaceutical Soars 5.32% Intraday on Positive Analyst Ratings

Stock Track

May 06

Ultragenyx Pharmaceutical's stock surged 5.32% during intraday trading on Wednesday, following a series of positive analyst actions from major financial institutions.

The price movement appears to be driven by favorable analyst coverage, with Wells Fargo maintaining a Buy rating on the stock and raising its price target from $45 to $47. Barclays also maintained a Buy rating with a $43 price target, contributing to positive sentiment around the healthcare company.

Analyst coverage of Ultragenyx Pharmaceutical has been active, with multiple firms weighing in on the stock. While Wedbush maintained a Neutral rating, the overall analyst sentiment appears positive, with the company having an average Buy rating and mean price target of $53.30 according to FactSet data.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1128830606"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1128830606\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1128830606?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 22:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128830606","market":"hk","top_or_hot":-1,"title":"Stock Track | Ultragenyx Pharmaceutical Soars 5.32% Intraday on Positive Analyst Ratings","media":"Stock Track","content":"<p>Ultragenyx Pharmaceutical's stock surged 5.32% during intraday trading on Wednesday, following a series of positive analyst actions from major financial institutions.</p><p>The price movement appears to be driven by favorable analyst coverage, with Wells Fargo maintaining a Buy rating on the stock and raising its price target from $45 to $47. Barclays also maintained a Buy rating with a $43 price target, contributing to positive sentiment around the healthcare company.</p><p>Analyst coverage of Ultragenyx Pharmaceutical has been active, with multiple firms weighing in on the stock. While Wedbush maintained a Neutral rating, the overall analyst sentiment appears positive, with the company having an average Buy rating and mean price target of $53.30 according to FactSet data.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Ultragenyx Pharmaceutical Soars 5.32% Intraday on Positive Analyst Ratings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Ultragenyx Pharmaceutical Soars 5.32% Intraday on Positive Analyst Ratings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-06 22:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ultragenyx Pharmaceutical's stock surged 5.32% during intraday trading on Wednesday, following a series of positive analyst actions from major financial institutions.</p><p>The price movement appears to be driven by favorable analyst coverage, with Wells Fargo maintaining a Buy rating on the stock and raising its price target from $45 to $47. Barclays also maintained a Buy rating with a $43 price target, contributing to positive sentiment around the healthcare company.</p><p>Analyst coverage of Ultragenyx Pharmaceutical has been active, with multiple firms weighing in on the stock. While Wedbush maintained a Neutral rating, the overall analyst sentiment appears positive, with the company having an average Buy rating and mean price target of $53.30 according to FactSet data.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RARE","symbol_name":"Ultragenyx Pharmaceutical Inc","start_time":0,"source_url":"","article_id":"1128830606","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128830606","pubTimestamp":1778077126,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Ultragenyx Pharmaceutical's stock surged 5.32% during intraday trading on Wednesday, following a series of positive analyst actions from major financial institutions.The price movement appears to be...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RARE":"Ultragenyx Pharmaceutical Inc"},"translate_title":"个股追踪|Ultragenyx Pharmaceutical盘中大涨5.32%因分析师正面评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RARE":1},"content_text":"Ultragenyx Pharmaceutical's stock surged 5.32% during intraday trading on Wednesday, following a series of positive analyst actions from major financial institutions.The price movement appears to be driven by favorable analyst coverage, with Wells Fargo maintaining a Buy rating on the stock and raising its price target from $45 to $47. Barclays also maintained a Buy rating with a $43 price target, contributing to positive sentiment around the healthcare company.Analyst coverage of Ultragenyx Pharmaceutical has been active, with multiple firms weighing in on the stock. While Wedbush maintained a Neutral rating, the overall analyst sentiment appears positive, with the company having an average Buy rating and mean price target of $53.30 according to FactSet data.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}